Spots Global Cancer Trial Database for vaginal atrophy
Every month we try and update this database with for vaginal atrophy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment | NCT03833726 | Atrophy;Vaginal Breast Cancer | Experimental: L... Sham Comparator... | 18 Years - 65 Years | Centro de Atenção ao Assoalho Pélvico | |
| Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy | NCT01697345 | Breast Cancer Vaginal Dryness Dyspareunia Sexual Health Q... | Testosterone | 50 Years - | Creighton University | |
| Vaginal Laser Therapy in Breast Cancer Survivors | NCT03738605 | Genitourinary S... Vaginal Atrophy Breast Cancer Dyspareunia | Microablative F... | - | National and Kapodistrian University of Athens | |
| Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors | NCT04493333 | Vaginal Atrophy Postmenopausal ... Breast Cancer F... Long-term Survi... | Vaginal Dehydro... Vaginal Polycar... | 18 Years - 70 Years | University of Arkansas | |
| Laser Treatment of Genito-urinary Syndrome in Women | NCT03238053 | Laser-Induced S... Breast Cancer Endometrial Can... Menopause Vaginal Atrophy Bladder, Overac... | Vaginal laser t... sham laser system | - | Herning Hospital | |
| Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients | NCT00607295 | Breast Cancer Vaginal Atrophy | clino-san vagin... | 20 Years - | Seoul National University Hospital | |
| Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial | NCT05379153 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Vaginal Atrophy | Laser Therapy Sham Interventi... Questionnaire A... Quality of Life... | 22 Years - | Alliance for Clinical Trials in Oncology | |
| A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting | NCT02413008 | Vaginal Atrophy | estriol Placebo | - | ITF Research Pharma, S.L.U. | |
| Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors | NCT04493333 | Vaginal Atrophy Postmenopausal ... Breast Cancer F... Long-term Survi... | Vaginal Dehydro... Vaginal Polycar... | 18 Years - 70 Years | University of Arkansas | |
| A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes | NCT03547089 | Vaginal Atrophy Genitourinary S... Vaginal Abnorma... Sexual Dysfunct... Sexual Problem | Viveve® | 18 Years - | Marina Plastic Surgery | |
| Evaluation of VagiVital® for Treatment of Vaginal Atrophy | NCT03998722 | Vaginal Atrophy | Vagivital | 18 Years - | PepTonic Medical AB | |
| A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes | NCT03547089 | Vaginal Atrophy Genitourinary S... Vaginal Abnorma... Sexual Dysfunct... Sexual Problem | Viveve® | 18 Years - | Marina Plastic Surgery | |
| LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2) | NCT04081805 | Vaginal Atrophy Vulva; Atrophy Breast Cancer | LASER Micro Ablative ... Promestriene | 30 Years - 75 Years | Federal University of São Paulo | |
| Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors | NCT03257670 | Dyspareunia | 4% Topical Lido... CO2RE fractiona... | 18 Years - | University of Cincinnati | |
| Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer | NCT03740945 | Vaginal Atrophy... | Placebo Prasterone (DHE... | 30 Years - 80 Years | EndoCeutics Inc. | |
| Evaluation of VagiVital® for Treatment of Vaginal Atrophy | NCT03998722 | Vaginal Atrophy | Vagivital | 18 Years - | PepTonic Medical AB | |
| Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients | NCT00607295 | Breast Cancer Vaginal Atrophy | clino-san vagin... | 20 Years - | Seoul National University Hospital | |
| Evaluation of VagiVital® for Treatment of Vaginal Atrophy | NCT03998722 | Vaginal Atrophy | Vagivital | 18 Years - | PepTonic Medical AB | |
| Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors | NCT03257670 | Dyspareunia | 4% Topical Lido... CO2RE fractiona... | 18 Years - | University of Cincinnati |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
